This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF' by A. Peikert et al., published in this issue on pages xxx
Sacubitril/valsartan is a combined neprilysin inhibitor/angiotensin II receptor blocker designed for...
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by...
Background: Heart failure is considered the most prevalent cause of cardiovascular mortality , in a...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
Background: Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin th...
Aims: Diabetes is associated with a faster rate of renal function decline in patients with heart f...
Background Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin thera...
Background Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin thera...
Sacubitril/valsartan is a combined neprilysin inhibitor/angiotensin II receptor blocker designed for...
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by...
Background: Heart failure is considered the most prevalent cause of cardiovascular mortality , in a...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
This article refers to 'Effects of sacubitril/valsartan versus valsartan on renal function in patien...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
International audienceAims: Diabetes is associated with a faster rate of renal function decline in p...
Background: Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin th...
Aims: Diabetes is associated with a faster rate of renal function decline in patients with heart f...
Background Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin thera...
Background Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin thera...
Sacubitril/valsartan is a combined neprilysin inhibitor/angiotensin II receptor blocker designed for...
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by...
Background: Heart failure is considered the most prevalent cause of cardiovascular mortality , in a...